Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5

Avian Diseases

Volumn 54, Issue SUPPL. 1, 2010, Pages 224-231

  Toro, Haroldo ^a   Van Ginkel, Frederik W ^a   Tang, De Chu C ^b   Schemera, Bettina ^a   Rodning, Soren ^a   Newton, Joseph ^a  

^a AUBURN UNIVERSITY   (United States)

^b Vaxin Incorporated   (United States)

Author keywords

Adenovirus; Avian influenza; Chickens; Pigs; Recombinant; Vaccination

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ADENOVIRUS; ANIMAL; BIRD DISEASE; CHICKEN; CONFERENCE PAPER; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; OOCYTE; ORTHOMYXOVIRUS INFECTION; SWINE; SWINE DISEASE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; CHICKENS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; OVUM; POULTRY DISEASES; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; SWINE; SWINE DISEASES; VACCINES, SYNTHETIC; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; HUMAN ADENOVIRUS TYPE 5; ORTHOMYXOVIRIDAE; SPONDIAS PURPUREA; SUIDAE;

EID: 77950257251     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8773-033109-Reg.1     Document Type: Conference Paper

References (37)

1. Albini, B., G. Wick, E. Rose, and E. Orlans. Immunoglobulin production in chicken Harderian glands. Int. Arch. Allergy Appl. Immunol. 47:23-34. 1974.
2. Bienenstock, J., J. Gauldie, and D. Y. Perey. Synthesis of IgG, IgA, IgM by chicken tissues: immunofluorescent and 14C amino acid incorporation studies. J. Immunol. 111:1112-1118. 1973.
3. Burns, R. B. Specific antibody production against a soluble antigen in the Harderian gland of the domestic fowl. Clin. Exp. Immunol. 26:371-374. 1976.
4. Capua, I., S. Marangon, M. Dalla Pozza, and U. Santucci. Vaccination for avian influenza in Italy. Vet. Rec. 147:751. 2000.
5. Choi, Y. K., T. D. Nguyen, H. Ozaki, R. J. Webby, P. Puthavathana, C. Buranathal, A. Chaisingh, P. Auewarakul, N. T. Hanh, S. K. Ma, P. Y. Hui, Y. Guan, J. S. Peiris, and R. G. Webster. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol. 79:10821-10825. 2005.
6. Crawley, J. F. Present status of infectious bronchitis immunization. In: Proc. Am. Vet. Med. Assoc. pp. 343-350. 1955.
7. Davelaar, F. G., A. Noordizij, and J. A. van der Donk. A study on the synthesis and secretion of immunoglobulins by the Harderian gland of the fowl after eyedrop vaccination against infectious bronchitis at 1-day-old. Avian Pathol. 11:63-79. 1982.
8. Ginkel, F. W. v., D. C. Tang, S. L. Gulley, and H. Toro. Induction of mucosal immunity in the avian Harderian gland with a replication deficient Ad-5 vector expressing avian influenza H5 hemagglutinin. Develop. Comp. Immunol. 33:28-34. 2009.
9. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95:2509-2514. 1998.
10. Hilleman, M. R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 20:3068-3087. 2002.
11. Jungherr, E. L., and R. E. Luginbuhl. Report on poultry respiratory disease control program for 1949 and suggestions for 1950. In: Proc. 22nd Annual Conference of Laboratory Workers Pullorum Disease Control, Burlington, VT. 1949.
12. Konz, J. O., R. C. Livingood, A. J. Bett, A. R. Goerke, M. E. Laska, and S. L. Sagar. Serotype specificity of adenovirus purification using anionexchange chromatography. Hum. Gene Ther. 16:1346-1353. 2005.
13. Lee, C. W., D. A. Senne, and D. L. Suarez. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22:3175-3181. 2004.
14. Lewis, J. A., E. L. Brown, and P. A. Duncan. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines. Dev. Biol. (Basel) 123:165-176. 2006.
15. Lipatov, A. S., Y. K. Kwon, L. V. Sarmento, K. M. Lager, E. Spackman, D. L. Suarez, and D. E. Swayne. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog. 4:e1000102. 2008.
16. Lochmuller, H., A. Jani, J. Huard, S. Prescott, M. Simoneau, B. Massie, G. Karpati, and G. Acsadi. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5:1485-1491. 1994.
17. Ludwig, S., L. Stitz, O. Planz, H. Van, W. Fitch, and C. Scholtissek. European swine virus as a possible source for the next influenza pandemic? Virology 212:555-561. 1995.
18. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208. 2006.
19. Sharma, J. M., and B. R. Burmester. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus. Avian Dis. 26:134-149. 1982.
20. Shi, Z., M. Zeng, G. Yang, F. Siegel, L. J. Cain, K. R. Van Kampen, C. A. Elmets, and D. C. Tang. Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines. J. Virol. 75:11474-11482. 2001.
21. Suarez, D. L., and S. Schultz-Cherry. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. Avian Dis. 44:861-868. 2000.
22. Swayne, D. E. Vaccines for List A poultry diseases: emphasis on avian influenza. Dev. Biol. (Basel) 114:201-212. 2003.
23. Swayne, D. E., J. R. Beck, and N. Kinney. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens pre-immunized with a fowl pox vaccine. Avian Dis. 44:132-137. 2000.
24. Swayne, D. E., D. A. Senne, and C. W. Beard. Influenza. In: Isolation and identification of avian pathogens, 4th ed. D. E. Swayne, J. R. Glisson, M. W. Jackwood, J. E. Pearson, and W. M. Reed, eds. American Association of Avian Pathologists, Kennett Square, PA. pp. 150-155. 1998.
25. Toro, H., P. Lavaud, P. Vallejos, and A. Ferreira. Transfer of IgG from serum to lacrimal fluid in chickens. Avian Dis. 37:60-66. 1993.
26. Toro, H., D. C. Tang, D. L. Suarez, M. J. Sylte, J. Pfeiffer, and K. R. van Kampen. Protective avian influenza in ovo vaccination with nonreplicating human adenovirus vector. Vaccine 25:2886-2891. 2007.
27. Toro, H., D. C. Tang, D. L. Suarez, J. Zhang, and Z. Shi. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 26:2640-2646. 2008.
28. Toro, H., V. L. van Santen, L. Li, S. B. Lockaby, E. van Santen, and F. J. Hoerr. Epidemiological and experimental evidence for immunodeficiency affecting avian infectious bronchitis. Avian Pathol. 35:1-10. 2006.
29. Ungchusak, K., P. Auewarakul, S. F. Dowell, R. Kitphati, W. Auwanit, P. Puthavathana, M. Uiprasertkul, K. Boonnak, C. Pittayawonganon, N. J. Cox, S. R. Zaki, P. Thawatsupha, M. Chittaganpitch, R. Khontong, J. M. Simmerman, and S. Chunsutthiwat. Probable person-toperson transmission of avian influenza A (H5N1). N. Engl. J. Med. 352:333-340. 2005.
30. van Ginkel, F. W., C.-J. Liu, J. W. Simecka, J.-Y. Dong, T. Greenway, R. A. Frizzell, H. Kiyono, J. R. McGhee, and D. W. Pascual. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and b-galactosidase. Hum. Gene Ther. 6:895-903. 1995.
31. Van Reeth, K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet. Res. 38:243-260. 2007.
32. Wakenell, P. S., T. Bryan, J. Schaeffer, A. Avakian, C. Williams, and C. Whitfill. Effect of in ovo vaccine delivery route on herpesvirus of turkeys/ SB-1 efficacy and viremia. Avian Dis. 46:274-280. 2002.
33. Wesley, R. D., and K. M. Lager. Evaluation of a recombinant human adenovirus-5 vaccine administered via needle-free device and intramuscular injection for vaccination of pigs against swine influenza virus. Am. J. Vet. Res. 66:1943-1947. 2005.
34. Wesley, R. D., and K. M. Lager. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Vet. Microbiol. 118:67-75. 2006.
35. Wesley, R. D., M. Tang, and K. M. Lager. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22:3427-3434. 2004.
36. World Organization for Animal Health (OIE), Food and Agriculture Organization of the United Nations (FAO). Recommendations of the OIE/ FAO International Scientific Conference on Avian Influenza [Internet]. Paris, France. [modified 2005 Apr 7-8 April]. Available from: www.oie.int/ eng/avian-influenza/OIE-FAO-Recom-05.pdf
37. Zhu, J., M. Grace, J. Casale, A. T. Chang, M. L. Musco, R. Bordens, R. Greenberg, E. Schaefer, and S. R. Indelicato. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector. Hum. Gene Ther. 10:113-121. 1999